Cargando…

Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals

The roseoloviruses, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7, can cause severe encephalitis or encephalopathy. In immunocompetent children, primary HHV-6B infection is occasionally accompanied by diverse clinical forms of encephalitis. Roseolovirus coinfections with heterologous viruses and del...

Descripción completa

Detalles Bibliográficos
Autores principales: Ongrádi, Joseph, Ablashi, Dharam V., Yoshikawa, Tetsushi, Stercz, Balázs, Ogata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329081/
https://www.ncbi.nlm.nih.gov/pubmed/27538995
http://dx.doi.org/10.1007/s13365-016-0473-0
_version_ 1782510987768758272
author Ongrádi, Joseph
Ablashi, Dharam V.
Yoshikawa, Tetsushi
Stercz, Balázs
Ogata, Masao
author_facet Ongrádi, Joseph
Ablashi, Dharam V.
Yoshikawa, Tetsushi
Stercz, Balázs
Ogata, Masao
author_sort Ongrádi, Joseph
collection PubMed
description The roseoloviruses, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7, can cause severe encephalitis or encephalopathy. In immunocompetent children, primary HHV-6B infection is occasionally accompanied by diverse clinical forms of encephalitis. Roseolovirus coinfections with heterologous viruses and delayed primary HHV-7 infection in immunocompetent adults result in very severe neurological and generalized symptoms. Recovery from neurological sequelae is slow and sometimes incomplete. In immunocompromised patients with underlying hematological malignancies and transplantation, frequent single or simultaneous reactivation of roseoloviruses elicit severe, lethal organ dysfunctions, including damages in the limbic system, brain stem, and hippocampus. Most cases have been due to HHV-6B with HHV-6A accounting for 2–3%. The most severe manifestation of HHV-6B reactivation is post-transplantation limbic encephalitis. Seizures, cognitive problems, and abnormal EEG are common. Major risk factors for HHV-6B-associated encephalitis include unrelated cord blood cell transplantation and repeated hematopoietic stem cell transplantation. Rare genetic disorders, male gender, certain HLA constellation, and immune tolerance to replicating HHV-6 in persons carrying chromosomally integrated HHV-6 might also predispose an individual to roseolovirus-associated brain damage. At this time, little is known about the risk factors for HHV-7-associated encephalitis. Intrathecal glial cell destruction due to virus replication, overexpression of proinflammatory cytokines, and viral mimicry of chemokines all contribute to brain dysfunction. High virus load in the cerebrospinal fluid, hippocampal astrogliosis, and viral protein expression in HHV-6B-associated cases and multiple microscopic neuronal degeneration in HHV-7-associated cases are typical laboratory findings. Early empirical therapy with ganciclovir or foscarnet might save the life of a patient with roseolovirus-associated encephalitis.
format Online
Article
Text
id pubmed-5329081
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-53290812017-03-13 Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals Ongrádi, Joseph Ablashi, Dharam V. Yoshikawa, Tetsushi Stercz, Balázs Ogata, Masao J Neurovirol Review The roseoloviruses, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7, can cause severe encephalitis or encephalopathy. In immunocompetent children, primary HHV-6B infection is occasionally accompanied by diverse clinical forms of encephalitis. Roseolovirus coinfections with heterologous viruses and delayed primary HHV-7 infection in immunocompetent adults result in very severe neurological and generalized symptoms. Recovery from neurological sequelae is slow and sometimes incomplete. In immunocompromised patients with underlying hematological malignancies and transplantation, frequent single or simultaneous reactivation of roseoloviruses elicit severe, lethal organ dysfunctions, including damages in the limbic system, brain stem, and hippocampus. Most cases have been due to HHV-6B with HHV-6A accounting for 2–3%. The most severe manifestation of HHV-6B reactivation is post-transplantation limbic encephalitis. Seizures, cognitive problems, and abnormal EEG are common. Major risk factors for HHV-6B-associated encephalitis include unrelated cord blood cell transplantation and repeated hematopoietic stem cell transplantation. Rare genetic disorders, male gender, certain HLA constellation, and immune tolerance to replicating HHV-6 in persons carrying chromosomally integrated HHV-6 might also predispose an individual to roseolovirus-associated brain damage. At this time, little is known about the risk factors for HHV-7-associated encephalitis. Intrathecal glial cell destruction due to virus replication, overexpression of proinflammatory cytokines, and viral mimicry of chemokines all contribute to brain dysfunction. High virus load in the cerebrospinal fluid, hippocampal astrogliosis, and viral protein expression in HHV-6B-associated cases and multiple microscopic neuronal degeneration in HHV-7-associated cases are typical laboratory findings. Early empirical therapy with ganciclovir or foscarnet might save the life of a patient with roseolovirus-associated encephalitis. Springer International Publishing 2016-08-18 2017 /pmc/articles/PMC5329081/ /pubmed/27538995 http://dx.doi.org/10.1007/s13365-016-0473-0 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Ongrádi, Joseph
Ablashi, Dharam V.
Yoshikawa, Tetsushi
Stercz, Balázs
Ogata, Masao
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title_full Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title_fullStr Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title_full_unstemmed Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title_short Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
title_sort roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329081/
https://www.ncbi.nlm.nih.gov/pubmed/27538995
http://dx.doi.org/10.1007/s13365-016-0473-0
work_keys_str_mv AT ongradijoseph roseolovirusassociatedencephalitisinimmunocompetentandimmunocompromisedindividuals
AT ablashidharamv roseolovirusassociatedencephalitisinimmunocompetentandimmunocompromisedindividuals
AT yoshikawatetsushi roseolovirusassociatedencephalitisinimmunocompetentandimmunocompromisedindividuals
AT sterczbalazs roseolovirusassociatedencephalitisinimmunocompetentandimmunocompromisedindividuals
AT ogatamasao roseolovirusassociatedencephalitisinimmunocompetentandimmunocompromisedindividuals